Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME).

The addition of the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME) to human peripheral blood mononuclear cells suppressed TNF secretion in a concentration dependent manner. At a concentration 10 mM TAME leukocyte TNF release was completely inhibited without decreasing the secretion of IL-1 alpha. Simultaneously exposing leukocytes to 10 mM TAME and either 1000 U/ml IFN-gamma or 10 micrograms/ml LPS reduced the quantity of TNF secreted by 75% and 47%, respectively, when compared with the effect of either IFN-gamma or LPS alone. TAME was most effective when added to leukocytes at the initiation of culture and the suppressive effects of this protease inhibitor were reversible by washing the cells. TAME suppressed TNF secretion without affecting either the level of TNF mRNA or the expression of cell surface cytokine. These findings suggest that leukocyte TNF secretion is dependent upon the action of one or more serine proteases.